Letter
Journal of Medicinal Chemistry, 2009, Vol. 52, No. 18 5589
(7) Hammers, A.; Asselin, M. C.; Turkheimer, F. E.; Hinz, R.; Osman,
S.; Hotton, G.; Brooks, D. J.; Duncan, J. S.; Koepp, M. J.
Balancing bias, reliability, noise properties and the need for para-
metric maps in quantitative ligand PET: [11C]diprenorphine
test-retest data. Neuroimage 2007, 38, 82–94.
(8) Schreckenberger, M.; Klega, A.; Grunder, G.; Buchholz, H. G.;
Scheurich, A.; Schirrmacher, R.; Schirrmacher, E.; Muller, C.;
Henriksen, G.; Bartenstein, P. Opioid receptor PET reveals the
psychobiologic correlates of reward processing. J. Nucl. Med. 2008,
49, 1257–1261.
(9) Hammers, A.; Asselin, M. C.; Hinz, R.; Kitchen, I.; Brooks, D. J.;
Duncan, J. S.; Koepp, M. J. Upregulation of opioid receptor
binding following spontaneous epileptic seizures. Brain 2007, 130,
1009–1016.
(10) Boecker, H.; Sprenger, T.; Spilker, M. E.; Henriksen, G.;
Koppenhoefer, M.; Wagner, K. J.; Valet, M.; Berthele, A.; Tolle,
T. R. The runner’s high: opioidergic mechanisms in the human
brain. Cereb. Cortex 2008, 18, 2523–2531.
(11) Melichar, J. K.; Hume, S. P.; Williams, T. M.; Daglish, M. R.;
Taylor, L. G.; Ahmad, R.; Malizia, A. L.; Brooks, D. J.; Myles,
J. S.; Lingford-Hughes, A.; Nutt, D. Using [11C]diprenorphine to
image opioid receptor occupancy by methadone in opioid addic-
tion: clinical and preclinical studies. J. Pharm. Exp. Ther. 2005, 312,
309–315.
(12) Hume, S. P.; Lingford-Hughes, A. R.; Nataf, V.; Hirani, E.;
Ahmad, R.; Davies, A. N.; Nutt, D. J. Low sensitivity of the
positron emission tomography ligand [11C]diprenorphine to ago-
nist opiates. J. Pharmacol. Exp. Ther. 2007, 322, 661–667.
(13) Luthra, S. K.; Brady, F.; Turton, D. R.; Brown, D. J.; Dowsett, K.;
Waters, S. L.; Jones, A. K. P.; Matthews, R. W.; Crowder, J. C.
Automated radiosyntheses of 6-O-methyl-11C]diprenorphine and
6-O-methyl-11C]buprenorphine from 3-O-trityl protected precur-
sors. Appl. Radiat. Isot. 1994, 45, 857–873.
(14) Bentley, K. W.; Hardy, D. G. Novel Analgesics and Molecular
Rearrangements in the Morphine-Thebaine Group. III. Alcohols
of the 6,14-endo-Ethenotetrahydrooripavine Series and Derived
Analogs of N-Allylnormorphine and -norcodeine. J. Am. Chem.
Soc. 1967, 89, 3281–3292.
(15) Linders, J. T. M.; Maat, L. Face selectivity of the Diels-Alder
reaction of thebaine-like morphinandienes, a computational ap-
proach. Bull. Soc. Chim. Belg. 1989, 98, 265–276.
pharmacology of 3-hydroxy-R,R-17-trimethyl-6β,14β-ethenomor-
phinan-7β-methanol, a novel deoxygenated diprenorphine analo-
gue. Recl. Trav. Chim. Pays-Bas. 1988, 107, 449–454.
(19) Bentley, K. W.; Hardy, D. G.; Meek, B. Novel Analgesics and
Molecular Rearrangements in the Morphine-Thebaine Group. II.
Alcohols Derived from 6,14-endo-Etheno- and 6,14-endo-Ethano-
tetrahydrothebaine. J. Am. Chem. Soc. 1967, 89, 3273–3280.
(20) Bentley, K. W.; Hardy, D. G.; Crocker, H. P.; Haddlesey, D. I.;
Mayor, P. A. Novel Analgesics and Molecular Rearrangements in
the Morphine-Thebaine Group. VI. Base-Catalyzed Rearrange-
ments in the 6,14-endo-Ethenotetrahydrothebaine Series. J. Am.
Chem. Soc. 1967, 89, 3312–3321.
(21) Simonin, F.; Befort, K.; Gaveriaux-Ruff, C.; Matthes, H.; Nappey,
V.; Lannes, B.; Micheletti, G.; Kieffer, B. The human δ-opioid
receptor: genomic organization, cDNA cloning, functional expres-
sion, and distribution in human brain. Mol. Pharmacol. 1994, 46,
1015–1021.
(22) Simonin, F.; Gaveriaux-Ruff, C.; Befort, K.; Matthes, H.; Lannes,
B.; Micheletti, G.; Mattei, M.-G.; Charron, G.; Bloch, B.; Kieffer,
B. Kappa-opioid receptor in humans: cDNA and genomic cloning,
chromosomal assignment, functional expression, pharmacology
and expression pattern in the central nervous system. Proc. Natl.
Acad. Sci. U.S.A. 1995, 92, 7006–7010.
(23) Wang, J. B; Johnson, P. S.; Persico, A. M.; Hawkins, A. L.; Griffin,
C. A.; Uhl, G. R. Human mu opiate receptor: cDNA and genomic
clones, pharmacologic characterization and chromosomal assign-
ment. FEBS Lett. 1994, 338, 217–222.
(24) Zhu, J.; Luo, L. Y.; Li, J. G.; Chen, C.; Liu-Chen, L. Y. Activation
of the cloned human kappa opioid receptor by agonists enhances
[
35S]GTPγS binding to membranes: determination of potencies
and efficacies of ligands. J.Pharmacol. Exp. Ther. 1997, 282, 676–
684.
(25) Alt, A.; Mansour, A.; Akil, H.; Medzihradsky, F.; Traynor, J. R.;
Woods, J. H. Stimulation of guanosine-50-O-(3-[35S]thio)tri-
phosphate binding by endogenous opioids acting at a cloned mu
receptor. J Pharmacol. Exp. Ther. 1998, 286, 282–288.
(26) Schmidhammer, H.; Burkard, W. P.; Eggstein-Aeppli, L.; Smith,
C. F. Synthesis and biological evaluation of 14-alkoxymorphinans.
2. (-)-N-(Cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one,
a selective mu opioid receptor antagonist. J. Med. Chem. 1989,
32, 418–421.
(16) Bentley, K. W.; Hardy, D. G. Novel Analgesics and Molecular
Rearrangements in the Morphine-Thebaine Group. I. Ketones
Derived from 6,14-endo-Ethenotetrahydrothebaine. J. Am. Chem.
Soc. 1967, 89, 3267–3273.
(17) Ghosh, A. C.; Portlock, D. E.; Dalzell, H. C.; Malmberg, C.;
Herlihy, P.; Razdan, R. K.; Duax, W. L.; Smith, D. Diels-Alder
Reaction of β-Dihydrothebaine and Its 4-Phenyl Ether with
Methyl Vinyl Ketone: Synthesis of 6,14-exo-Ethenomorphinans.
J. Org. Chem. 1983, 48, 4137–4139.
(27) Hooker, J. M.; Patel, V.; Kothari, S.; Schiffer, W. K. Metabolic
Changes in the Rodent Brain after Acute Administration of
Salvinorin A. Mol. Imaging Biol. 2009, 11, 137–143.
(28) Munro, T. A.; Rizzacasa, M. A.; Roth, B. L.; Toth, B. A.; Yan, F.
Studies toward the pharmacophore of salvinorin A, a potent kappa
opioid receptor agonist. J. Med. Chem. 2005, 48, 345–348.
(29) Mansour, A.; Khachaturian, H.; Lewis, M. E.; Akil, H.; Watson,
S. J. Anatomy of CNS opioid receptors. Trends. Neurosci. 1988, 11,
308–314.
(18) Linders, J. T. M.; Kokje, J. P.; Overhand, M.; Lie, T. S.; Maat, L.
Diels-Alder reaction of 6-demethoxy-β-dihydrothebaine with
methyl vinyl ketone using microwave heating; preparation and
(30) Hjornevik, T.; Schoultz, B. W.; Marton, J. Gjerstad, J.; Drzezga, A.
Henriksen, G.; Willoch F. C-fibre LTP is associated with reduced
opioid neurotransmission in rat brain. Submitted for publication.